— Know what they know.
Not Investment Advice

Financial News

Sentiment -1.9 4966 articles 2477 bullish 1233 bearish Full Index →
Dow Surges Over 300 Points; Chewy Shares Jump On Upbeat Earn

Dow Surges Over 300 Points; Chewy Shares Jump On Upbeat Earnings

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 300 points on Wednesday. The Dow traded up 0.79% to...
Dow Surges Over 300 Points; Chewy Shares Jump On Upbeat Earn

Dow Surges Over 300 Points; Chewy Shares Jump On Upbeat Earnings

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 300 points on Wednesday. The Dow traded up 0.79% to...
Dow Surges Over 300 Points; Chewy Shares Jump On Upbeat Earn

Dow Surges Over 300 Points; Chewy Shares Jump On Upbeat Earnings

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 300 points on Wednesday. The Dow traded up 0.79% to...
Dow Surges Over 300 Points; Chewy Shares Jump On Upbeat Earn

Dow Surges Over 300 Points; Chewy Shares Jump On Upbeat Earnings

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 300 points on Wednesday. The Dow traded up 0.79% to...
📰

Portnoy Law Firm Announces Class Action on Behalf of Atara Biotherapeutics, Inc. Investors

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
The OpenAI Effect: How Amazon Is Turning Cloud Demand Into A

The OpenAI Effect: How Amazon Is Turning Cloud Demand Into A Power Play

Amazon.com Inc (NASDAQ:AMZN) is seeing strong cloud-driven momentum even as near-term cost pressures persist, according to JPMorgan. ...
Datavault AI Teams Up With Boxing Star Moses Itauma

Datavault AI Teams Up With Boxing Star Moses Itauma

Datavault AI Inc (NASDAQ:DVLT) is expanding its sports and technology strategy through a new athlete partnership while raising its growth...
Short Seller Report Alleges ADMA Biologics Financial Misrepr

Short Seller Report Alleges ADMA Biologics Financial Misrepresentation

ADMA Biologics Inc. (NASDAQ:ADMA) shares are down on Wednesday following a report from Culper Research that raised concerns about the company's...
📰

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES, March 25, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is...
Maze Therapeutics Stock Falls Despite Strong Phase 2 Kidney

Maze Therapeutics Stock Falls Despite Strong Phase 2 Kidney Drug Data For MZE829

Maze Therapeutics Inc. (NASDAQ:MAZE) shares are down on Wednesday following the announcement of topline data from the Phase 2 HORIZON trial of...
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 36.0% to $0.39 during Wednesday's regular session. The company's market cap...
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 36.0% to $0.39 during Wednesday's regular session. The company's market cap...
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 36.0% to $0.39 during Wednesday's regular session. The company's market cap...
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 36.0% to $0.39 during Wednesday's regular session. The company's market cap...
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 36.0% to $0.39 during Wednesday's regular session. The company's market cap...
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 36.0% to $0.39 during Wednesday's regular session. The company's market cap...
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 36.0% to $0.39 during Wednesday's regular session. The company's market cap...
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 36.0% to $0.39 during Wednesday's regular session. The company's market cap...
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 36.0% to $0.39 during Wednesday's regular session. The company's market cap...
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 36.0% to $0.39 during Wednesday's regular session. The company's market cap...
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 36.0% to $0.39 during Wednesday's regular session. The company's market cap...
Cancer Drug Developer Nanobiotix Denies Any Active Takeover

Cancer Drug Developer Nanobiotix Denies Any Active Takeover Process

Nanobiotix S.A. (NASDAQ:NBTX) shares are up on Wednesday as the company responds to recent media speculation regarding potential acquisition...
Cancer Drug Developer Nanobiotix Denies Any Active Takeover

Cancer Drug Developer Nanobiotix Denies Any Active Takeover Process

Nanobiotix S.A. (NASDAQ:NBTX) shares are up on Wednesday as the company responds to recent media speculation regarding potential acquisition...
Cancer Drug Developer Nanobiotix Denies Any Active Takeover

Cancer Drug Developer Nanobiotix Denies Any Active Takeover Process

Nanobiotix S.A. (NASDAQ:NBTX) shares are up on Wednesday as the company responds to recent media speculation regarding potential acquisition...
Cancer Drug Developer Nanobiotix Denies Any Active Takeover

Cancer Drug Developer Nanobiotix Denies Any Active Takeover Process

Nanobiotix S.A. (NASDAQ:NBTX) shares are up on Wednesday as the company responds to recent media speculation regarding potential acquisition...
📰

$100 Invested In argenx 5 Years Ago Would Be Worth This Much Today

argenx (NASDAQ:ARGX) has outperformed the market over the past 5 years by 9.82% on an annualized basis producing an average annual return of 20.55%....
📰

ANI (ANIP) is an Incredible Growth Stock: 3 Reasons Why

ANI (ANIP) is well positioned to outperform the market, as it exhibits above-average growth in financials.
📰

Looking for a Growth Stock? 3 Reasons Why Star Equity Holdings (STRR) is a Solid Choice

Star Equity Holdings (STRR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
NVO Eyes Global Expansion of Diabetes Drug After Strong Phas

NVO Eyes Global Expansion of Diabetes Drug After Strong Phase II Data

Novo Nordisk reports phase II data for UBT251, showing strong HbA1c reduction and weight loss. It plans for global studies and China phase III trials.
NVO Eyes Global Expansion of Diabetes Drug After Strong Phas

NVO Eyes Global Expansion of Diabetes Drug After Strong Phase II Data

Novo Nordisk reports phase II data for UBT251, showing strong HbA1c reduction and weight loss. It plans for global studies and China phase III trials.
📰

NVO Eyes Global Expansion of Diabetes Drug After Strong Phase II Data

Novo Nordisk reports phase II data for UBT251, showing strong HbA1c reduction and weight loss. It plans for global studies and China phase III trials.
NVO Eyes Global Expansion of Diabetes Drug After Strong Phas

NVO Eyes Global Expansion of Diabetes Drug After Strong Phase II Data

Novo Nordisk reports phase II data for UBT251, showing strong HbA1c reduction and weight loss. It plans for global studies and China phase III trials.
NVO Eyes Global Expansion of Diabetes Drug After Strong Phas

NVO Eyes Global Expansion of Diabetes Drug After Strong Phase II Data

Novo Nordisk reports phase II data for UBT251, showing strong HbA1c reduction and weight loss. It plans for global studies and China phase III trials.
« Prev 1 16 17 18 19 20 80 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms